ASCARI, EDOARDO
 Distribuzione geografica
Continente #
NA - Nord America 3.851
AS - Asia 3.096
EU - Europa 2.813
SA - Sud America 335
AF - Africa 41
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 7
Totale 10.155
Nazione #
US - Stati Uniti d'America 3.777
CN - Cina 1.912
IE - Irlanda 686
SG - Singapore 600
UA - Ucraina 468
FI - Finlandia 365
DE - Germania 339
HK - Hong Kong 305
RU - Federazione Russa 284
BR - Brasile 279
SE - Svezia 272
GB - Regno Unito 139
IT - Italia 109
VN - Vietnam 102
FR - Francia 52
CA - Canada 50
IN - India 49
AR - Argentina 25
BD - Bangladesh 19
NL - Olanda 19
ZA - Sudafrica 19
BE - Belgio 17
IR - Iran 17
JP - Giappone 17
PL - Polonia 15
MX - Messico 14
ES - Italia 13
AU - Australia 11
ID - Indonesia 10
EC - Ecuador 9
AT - Austria 7
PK - Pakistan 7
SA - Arabia Saudita 7
VE - Venezuela 7
DK - Danimarca 6
IQ - Iraq 6
UZ - Uzbekistan 6
CO - Colombia 5
MA - Marocco 5
NP - Nepal 5
PY - Paraguay 5
AE - Emirati Arabi Uniti 4
CZ - Repubblica Ceca 4
DZ - Algeria 4
EU - Europa 4
IL - Israele 4
JO - Giordania 4
RO - Romania 4
EG - Egitto 3
GE - Georgia 3
GR - Grecia 3
LT - Lituania 3
TR - Turchia 3
AZ - Azerbaigian 2
BB - Barbados 2
BY - Bielorussia 2
CL - Cile 2
CR - Costa Rica 2
JM - Giamaica 2
KE - Kenya 2
KR - Corea 2
KZ - Kazakistan 2
LB - Libano 2
LK - Sri Lanka 2
ML - Mali 2
MU - Mauritius 2
TN - Tunisia 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
BH - Bahrain 1
BO - Bolivia 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CY - Cipro 1
GT - Guatemala 1
HN - Honduras 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
MD - Moldavia 1
MY - Malesia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PA - Panama 1
PE - Perù 1
PH - Filippine 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
UY - Uruguay 1
Totale 10.155
Città #
Dublin 684
Chandler 591
Jacksonville 570
Nanjing 455
Hong Kong 300
Beijing 287
Dallas 285
Ashburn 279
Singapore 245
Boardman 202
Nanchang 191
Princeton 137
Shenyang 126
Hebei 125
Lawrence 125
Medford 121
Changsha 114
Wilmington 112
Jiaxing 99
Los Angeles 99
Helsinki 91
Ann Arbor 77
Tianjin 74
Hangzhou 72
Munich 70
Moscow 57
New York 54
Buffalo 48
Shanghai 44
Milan 43
Redondo Beach 43
Turku 37
Ho Chi Minh City 35
Woodbridge 33
Norwalk 28
São Paulo 25
Hanoi 24
Verona 24
Montreal 20
Seattle 20
Fairfield 19
Toronto 19
Brussels 17
Chicago 17
Tokyo 16
Guangzhou 15
Houston 15
Warsaw 14
Denver 13
Johannesburg 13
Kunming 13
Jinan 11
Orem 11
San Francisco 11
Santa Clara 11
Zhengzhou 11
Brooklyn 10
The Dalles 10
Auburn Hills 9
Boston 9
Brasília 9
Chennai 9
Des Moines 9
Falkenstein 9
London 9
Phoenix 9
Poplar 9
Ningbo 8
Piscataway 8
San Genesio Ed Uniti 8
Taizhou 8
Atlanta 7
Belo Horizonte 7
Changchun 6
Columbus 6
Falls Church 6
Haiphong 6
Manchester 6
Orange 6
Rio de Janeiro 6
Andover 5
Ardabil 5
Fuzhou 5
Lanzhou 5
Melbourne 5
Mexico City 5
Quito 5
Rome 5
Tashkent 5
Amman 4
Amsterdam 4
Campinas 4
Shijiazhuang 4
Sorocaba 4
Stockholm 4
Barueri 3
Biên Hòa 3
Bắc Ninh 3
Cleveland 3
Colombo 3
Totale 6.565
Nome #
5' Nucleotidase in chronic B cell leukemias: a cytochemical and ultrastructural study 132
A combination regimen of idarubicin and cytosine arabinoside for patients with high-risk myelodysplastic syndromes 126
A modified high-dose dexamethasone regimen for primary systemic amyloidosis 125
A modified high-dose dexamethasone regimen for primary systemic (AL) amyloidosis. 120
[Biochemical modifications of the erythrocyte membrane in various red cell disorders] 115
Anomalous erythrocytes produced by rabbits with liver damage. 114
[Pathogenetic mechanisms of chronic myeloid leukemia and the antiproliferative effects of alpha and gamma interferons] 114
Characterization of immunoglobulin variable regions of two human pathogenic monoclonal cryocrystalglobulins 113
Interaction of the anthracycline 4'-iodo-4'-deoxydoxorubicin with amyloid fibrils:inhibition of amyloidogenesis. 113
Ageing of rabbit red cells in vitro: membrane modifications and their possible role in red cell survival in vivo. 111
Acute promyelocitic leukemia toluidine blue subtype. 109
AMYLOIDOSIS AL 108
Cytokinetic changes in the peripheral blood of leukemic patients during cytostatic therapy. VI. Effect of arabinosylcytosine. 107
Severe platelet disfunction in a patient with autoantibodies against membrane glycoproteins IIb-IIIa 107
Acute phase proteins and prognosis in multiple myeloma. 107
A prospective, controlled, non-randomized study on prophylactic parenteral dichloromethylene bisphosphonate (clodronate) in multiple myeloma. 106
Response to first-line chemotherapy and long-term survival in patients with multiple myeloma: results of the MM87 prospective randomised protocol 104
A further case of myeloproliferative syndrome with reciprocal translocation (8;13)(p11;q12) 104
The myelodysplastic syndromes: predictive value of eight prognostic systems in 143 cases from a single institution. 103
- Hematological values from quantitative buffy coat analysis (QBC II) system: evaluation in an hematological/oncological outpatient section 102
Acquired immune thrombastenia: a new bleeding disorder. 99
An atypical myeloproliferative disorder with high thrombotic risk and slow disease progression. 98
Silymarine during maintenance therapy of acute promyelocytic leukemia. 98
Advanced breast cancer: a randomized study of different doses of epirubicin associated with fixed doses of cyclophosphamide and 5-fluorouracil. 97
Anemie megaloblastiche. 97
[Glycoproteins of the erythrocyte membrane in normal and pathological conditions] 97
A plea to overcome th concept of "staging" and related inadequacy in multiple myeloma. 96
Long-term effects of parenteral dichloromethylene bisphosphonate (CL2MBP) on bone disease of myeloma patients treated with chemotherapy. 96
Reactive hemophagocytosis in Ki-1 positive largeb cell lymphoma: a case study. 95
Acquired cyclic thrombocytopenia-thrombocytosis with periodic defect of platelet function. 95
The clinical value of tumor burden at diagnosis in Hodgkin lymphoma 93
Response to cyclosporin A and rhG-CSF in a case of aplastic anemia. 93
On the usefulness of PAS reaction for the prognosis of acute lymphoblastic leukemia. 93
Effetti sistemici della terapia trombolitica.[Systemic effects of thrombolytic therapy]. 92
[Prophylaxis and therapy of neuro-meningeal involvement of acute lymphoblastic leukemia. Case reports and critical review of literature (author's transl)] 92
Analysis of Vlambda-Jlambda expression in plasma cells from primary (AL) amyloidosis and normal bone marrow identifies 3r (lambda III) as a new amyloid-associated germline gene segment 92
IMMUNOENZYMATIC DETECTION OF PROTEINS TRANSFERRED ON NITROCELLULOSE AFTER FIXATION AND STAINING IN POLYACRYLAMIDE GEL 91
Possible evolution of human parvovirus B19 infection into erythroleukemia 91
[Pure acute monocytic leukaemia: morphological, cytochemical and clinical study of 14 cases (author's transl)]. 91
Survivin expression, apoptosis and proliferation in chronic myelomonocytic leukemia 87
Presentation features of monoclonal gammopathies: analysis of 684 newly diagnosed cases. 86
Biologia e clinica del mieloma multiplo. 86
A prospective, controlled, nonrandomized study on prophylactic parenteral dichloromethylene bisphosphonate (clodronate) in multiple-myeloma. 86
Structural features of two monoclonal cryocrystalglobulins causing a rheumatic syndrome with vasculitis 84
Sequential administration of interleukin-3 and granulocyte-macrophage colony-stimulating factor following intensified, accelerated CEE (cyclophosphamide, epirubicin, etoposide) chemotherapy: cytokinetic effects on bone marrow hematopoietic progenitors. 83
Changing clinical presentation of multiple myeloma. 82
Sequential vincristine, arabinosylcytosine and daunomycin in acute leukemia: a preliminary report. 82
CHARACTERIZATION OF ANTI-STREPTOLYSIN O ACTIVITY OF A HUMAN MONOCLONAL IgG LAMDA. 82
Significance of marrow-blood barrier for CFU-GM in patients with acute nonlymphoid leukemia (AnLL) 82
STUDY OF THREE PATIENTS WITH MONOCLONAL GAMMAPATHIES AND "LUPUS-LIKE" ANTICOAGULANTS. 81
The effect of red blood cells on platelet aggregation; a study with the whole blood aggregometer 81
High versus standard dose methylprednisolone in the acute phase of idiopathic thrombotic thrombocytopenic purpura: a randomized study. 81
Membrane CD22 defines circulating myeloma-related cells as mature or later B cells 81
RELEVANCE OF CLASS, MOLECULAR WEIGHT AND ISOELECTRIC POINT IN PREDICTING HUMAN LIGHT CHAIN AMYLOIDOGENICITY. 80
Effect of anagrelide on platelet count and function in patients with thrombocytosis and myeloproliferative disorders. 80
Clinical relevance of two in vitro tests based on CFU-GM assay in the study of granulopoietic failure 80
Applicazioni cliniche dei fattori di crescita emopoietici. 79
Fisiopatologia dell'eritrocito. 79
Morphological features and prognostic implication in a retrospective analysis of 370 patients with myelodysplastic syndrome 79
CYCLIC THROMBOCYTOPENIA-THROMBOCYTOSIS WITH A PERIODIC DEFECT OF PLATELET-FUNCTION - REPORT OF A CASE 79
Acute non-lymphoblastic leukemia. Correlation between clinical and hematological parameters in 87 adult patients. 79
Left ventricular function in colon cancer patients receiving adjuvant fluoro-folate chemotherapy. An echocardiographic study. 78
Effects of desferrrioxamine on normal and leukemic human hematopoietic cell growth: in vitro and in vivo studies 78
Glycopeptides of erythrocyte membranes in some hematological disorders 78
Cancer chemotherapy-related thrombotic thrombocytopeic purpura: biological evidence of increased nitric oxide production. 78
Expression of p53, bcl-2 and ras oncoproteins in acute leukemias and myelodysplastic syndromes 78
Osteonecrosi avascolare del massiccio facciale in corso di terapia con bisfosfonati [Avascular jaw osteonecrosis associated with bisphophonate therapy]. 78
Clinical and biological effects of treatment with amifostine in myelodysplastic syndromes 78
[Chronic granulomatous disease with sea-blue histiocytosis: a case report (author's transl)]. 78
Intravenous prostacyclin (as epoprostenol) infusion in thrombotic thrombocytopenic purpura. Four case reports and review of the literature. Italian Cooperative Group for Thrombotic Thrombocytopenic Purpura 78
Serum N-terminal pro-brain natriuretic peptide is a sensitive marker of myocardial dysfunction in AL amyloidosis 77
Treatment of thrombotic thrombocytopenic purpura with high-dose immunoglobulins. Results in 17 patients. Italian Cooperative Group for TTP 77
International prognostic scoring system and other prognostic systems for myelodysplastic syndromes. 76
The syndrome of abnormal chromatin clumping in leucocytes: clinical and biological study of a case. 75
Chemotherapy-induced leukonychia 75
Evidence of a hypercoagulable state in patients with acute lymphoblastic leukemia treated with low dose of E. coli L-asparaginase: a GIMEMA study. 74
Cell cycle status and apoptosis of hematopoietic progenitor cells released into the peripheral blood after taxanes anf granulocyte colony-stimulating factor in breast cancer patients 73
Applicazioni cliniche della citometria. 73
Vincristine sulfate for the treatment of thrombotic thrombocytopenic purpura refractory to plasma-exchange. The Italian Cooperative Group for TTP 73
Behaviour of young and old desialylated rabbit erythrocytes in vivo. 71
Acute promyelocytic leukemia: morphological and clinical features. 71
Structural modifications in membrane glycoproteins during the erythrocyte life-span. 70
In vivo behaviour of neuraminidase-treated rabbit erythrocytes and reticulocytes 70
Idarubicin and cytosine arabinoside in the induction and maintenance therapy of high risk myelodysplastic syndromes 70
Lymphocyte reactivity in chronic lymphocytic leukaemia: effect of repeated and prolonged stimulation with PHA and PWM. 70
Cell kinetics in human malignancies studied with in vivo administration of bromodeoxyuridine and flow cytometry 69
IL MIELOMA MULTIPLO 69
Bone marrow myeloid cell kinetics during treatment of small cell carcinoma of the lung with chemotherapy not associated and associated with granulocyte-macrophage colony stimulating factor. 68
Flow cytometric analysis of multidrug resistance antigen (p glicoprotein) and DNA ploidy in human colon cancer 68
Terapia del mieloma multiplo. 68
Experience with poorly myelosuppressive chemotherapy schedules for advanced myeloma. 68
Tetrahydrofolate dehydrogenase cytochemistry in acute lymphoblastic leukemia. 67
Membrane sialic acid and behaviour in vivo of rabbit "stress" macroreticulocytes. 67
Antiplatelet agents in thrombotic thrombocytopenic purpura (TTP). Results of a randomized multicenter trial by the Italian Cooperative Group for TTP 67
Establishment and characterization of a B-cell line derived from a patient with a myelodysplastic syndrome which expresses myelomonocytic and lymphoid markers. 66
Erythrocyte membrane modifications in chronic granulocytic leukaemia 65
Flow cytometric analysis of paraffin embedded material in human gastric cancer. 65
Loss of the Y chromosome in smoldering acute leukemia. 65
Immunocytochemical detection of factor XIII A--subunit in acute leukemia. 64
Bone marrow morphology and proliferative activity in acquired immunodeficiency syndrome. 64
Totale 8.632
Categoria #
all - tutte 43.235
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.235


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021589 0 0 0 0 0 129 3 134 32 137 117 37
2021/2022650 9 1 21 10 24 35 12 35 23 32 88 360
2022/20231.811 217 129 21 136 183 174 0 85 777 9 54 26
2023/2024550 80 92 25 59 51 133 15 32 7 14 25 17
2024/20251.566 44 142 37 52 25 49 53 109 391 47 183 434
2025/20262.062 275 254 441 523 421 148 0 0 0 0 0 0
Totale 10.229